BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 7, 2019
View Archived Issues
Immunotherapeutic targeting of CD81 selectively kills B-cell lymphoma cells
Read More
Androgen receptor loss linked to increased transcription, translation
Read More
Parasite food fight
Read More
Recruitment ongoing in phase I study of DN-1406131
Read More
IKM-5 demonstrates promising safety and efficacy in breast cancer models
Read More
DKN-01 plus Keytruda shows positive clinical results in KEYNOTE-731 study
Read More
Interim data reported from ongoing phase Ib study of EDP-1815 in psoriasis
Read More
Syros Pharmaceuticals describes new CDK7/cyclin H inhibitors
Read More
Caspase-1 found to be protective in the pathogenesis of SLE
Read More
Indoleamine 2,3-dioxygenase 1 inhibitors discovered at Adlai Nortye
Read More
Enanta Pharmaceuticals discloses anti-hepatitis B virus compounds
Read More
New PI3K-delta inhibitors patented by Calitor Sciences, Sunshine Lake Pharma
Read More
Array BioPharma identifies new RET inhibitors
Read More
Oncternal opens enrollment in phase II portion of CIRLL study of cirmtuzumab plus ibrutinib
Read More
Topoisomerase inhibitors strongly downregulate MYC through binding the promoter G-quadruplex
Read More
Radius initiates phase III wearABLe study of abaloparatide-patch
Read More
Kineta receives further support to develop LHF-535 after positive phase I results
Read More
Noggin and asporin are diagnostic markers of NAFLD
Read More
FDA and Novartis comment on data accuracy issues with recently approved Zolgensma
Read More
DNARx to develop DNA-encoded gene-based therapeutics for pandemic influenza
Read More
Phase IIb study of OPT-302 in wet AMD meets primary endpoint
Read More
Promising new target identified for tissue regeneration
Read More
Topline results show BROADEN study of Waylivra met primary endpoint
Read More
Lynparza leads to improvement in men with mCRPC and HRR gene mutation
Read More
Positive preliminary data reported from phase I trial of INmune Bio's INB-03
Read More